RAStik: A Retrospective Cohort Analysis of Survival and Treatment Outcomes of Docetaxel in KRAS G12C Mutated Locally Advanced or Metastatic NSCLC (20190411)

First published 09/12/2020

Last updated 26/07/2023

EU PAS number:

EUPAS38357

Study

Finalised

Documents

Study protocol

Initial protocol

Protocol-Published Original Sotorasib 20190411

English (649.17 KB - PDF) View document

Study results

20190411_ORSR_Abstract_Redacted

English (121.5 KB - PDF) View document

Study report

Other information

Secondary tabs